Schifano F - Search Results

1

A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.

Chiappini S, Schifano F. Chiappini S, et al. Among authors: schifano f. CNS Drugs. 2016 Jul;30(7):647-54. doi: 10.1007/s40263-016-0359-y. CNS Drugs. 2016. PMID: 27312320

2

The Gamblers' Temperament and Character Inventory (TCI) personality profile.

Janiri L, Martinotti G, Dario T, Schifano F, Bria P. Janiri L, et al. Among authors: schifano f. Subst Use Misuse. 2007;42(6):975-84. doi: 10.1080/10826080701202445. Subst Use Misuse. 2007. PMID: 17613958

3

The "Eyeballing" technique: an emerging and alerting trend of alcohol misuse.

Bersani FS, Corazza O, Albano G, Bruschi S, Minichino A, Vicinanza R, Bersani G, Martinotti G, Schifano F. Bersani FS, et al. Among authors: schifano f. Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2311-7. Eur Rev Med Pharmacol Sci. 2015. PMID: 26166661 Review.

4

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

Schifano F, Chiappini S. Schifano F, et al. PLoS One. 2018 Oct 4;13(10):e0204443. doi: 10.1371/journal.pone.0204443. eCollection 2018. PLoS One. 2018. PMID: 30286103 Free PMC article.

5

Is there a potential of misuse for Magnolia officinalis compounds/metabolites?

Schifano F, Guarino V, Papanti DG, Baccarin J, Orsolini L, Corkery JM. Schifano F, et al. Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2595. Epub 2017 May 18. Hum Psychopharmacol. 2017. PMID: 28517911 Review.

6

Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics' ('Spice') Intake?

Orsolini L, Papanti D, Corkery J, De Luca MA, Cadoni C, Di Chiara G, Schifano F. Orsolini L, et al. Among authors: schifano f. CNS Neurol Disord Drug Targets. 2017;16(5):585-591. doi: 10.2174/1871527316666170413101257. CNS Neurol Disord Drug Targets. 2017. PMID: 28412917 Review.

7

Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update.

De Luca MA, Di Chiara G, Cadoni C, Lecca D, Orsolini L, Papanti D, Corkery J, Schifano F. De Luca MA, et al. Among authors: schifano f. CNS Neurol Disord Drug Targets. 2017;16(5):598-609. doi: 10.2174/1871527316666170413113246. CNS Neurol Disord Drug Targets. 2017. PMID: 28412916 Review.

8

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.

Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti Posocco F, Cinosi E, Simonato P, Martinotti G, Bersani G, Schifano F. Bersani FS, et al. Among authors: schifano f. Biomed Res Int. 2014;2014:734749. doi: 10.1155/2014/734749. Epub 2014 Jul 3. Biomed Res Int. 2014. PMID: 25105138 Free PMC article. Review.

9

β-2 Agonists as Misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency Pharmacovigilance Database Reports.

Milano G, Chiappini S, Mattioli F, Martelli A, Schifano F. Milano G, et al. Among authors: schifano f. Basic Clin Pharmacol Toxicol. 2018 Aug;123(2):182-187. doi: 10.1111/bcpt.12991. Epub 2018 Apr 6. Basic Clin Pharmacol Toxicol. 2018. PMID: 29498199

10

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Schifano F, Chiappini S, Corkery JM, Guirguis A. Schifano F, et al. Brain Sci. 2018 Apr 22;8(4):73. doi: 10.3390/brainsci8040073. Brain Sci. 2018. PMID: 29690558 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results